The treatment and outcome of a pulmonary sarcomatoid carcinoma patient infected with SARS-CoV-2

In December 2019, an outbreak of the pandemic acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread around the world. [1 –3] So far, Coronavirus Disease-19 (COVID-19) has threatened nearly 5,000,000 people, and World Health Organization (WHO) has declared it as a public health emergency of international concern. Specifically, cancer patients are more vulnerable to infections because of their poor health status and s ystemic immunosuppressive states caused by cancer and anticancer treatments.

Source: Lung Cancer - June 11, 2020 Category: Cancer & Oncology Authors: Kai Wang, Yang Liu, Tian Hu, Yumei Liu, Chao Liu Source Type: research